UPDATE: Goldman Sachs Loweres Intellia Therapeutics (NTLA) PT to $159
Tweet Send to a Friend
(Updated - August 4, 2022 4:12 PM EDT)Goldman Sachs analyst Salveen Richter maintains Intellia Therapeutics (NASDAQ: NTLA) with a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
